tirzepatide for psoriatic arthritis What Is Used for? Approved and Potential Uses The potential role of GLP-1

Thromb Res 163:162171

Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, powerfully resolves liver fat in NAFLD

Although cosmeceutical products for topical use are not required to undergo FDA clearance, Ariessence advertises that their company has 4 FDA approvals in other medical treatments (GEM 21S, Augment, AugmentInjectable, and Regranex)

That said, providers may want to understand the circumstances of recent weight gain to ensure medication is appropriate

In patients with moderate to severe renal impairment (creatinine clearance less than 50 mL/min), the recommended starting dose is Januvia 50 mg once daily

McCann says children should avoid it unless directed by a physician